174 related articles for article (PubMed ID: 36831129)
1. NRF2 and Bip Interconnection Mediates Resistance to the Organometallic Ruthenium-Cymene Bisdemethoxycurcumin Complex Cytotoxicity in Colon Cancer Cells.
Garufi A; Pettinari R; Marchetti F; Cirone M; D'Orazi G
Biomedicines; 2023 Feb; 11(2):. PubMed ID: 36831129
[TBL] [Abstract][Full Text] [Related]
2. NRF2 activation in BON‑1 neuroendocrine cancer cells reduces the cytotoxic effects of a novel Ruthenium(II)‑curcumin compound: A pilot study.
Garufi A; Pettinari R; Monteonofrio L; Puliani G; Virdia I; Appetecchia M; Marchetti F; Cirone M; Soddu S; D'Orazi G
Oncol Rep; 2024 Feb; 51(2):. PubMed ID: 38186307
[TBL] [Abstract][Full Text] [Related]
3. The in vitro antitumor activity of arene-ruthenium(II) curcuminoid complexes improves when decreasing curcumin polarity.
Caruso F; Pettinari R; Rossi M; Monti E; Gariboldi MB; Marchetti F; Pettinari C; Caruso A; Ramani MV; Subbaraju GV
J Inorg Biochem; 2016 Sep; 162():44-51. PubMed ID: 27293144
[TBL] [Abstract][Full Text] [Related]
4. Ruthenium(II) 1,4,7-trithiacyclononane complexes of curcumin and bisdemethoxycurcumin: Synthesis, characterization, and biological activity.
Pettinari R; Marchetti F; Tombesi A; Duan F; Zhou L; Messori L; Giacomelli C; Marchetti L; Trincavelli ML; Marzo T; La Mendola D; Balducci G; Alessio E
J Inorg Biochem; 2021 May; 218():111387. PubMed ID: 33721720
[TBL] [Abstract][Full Text] [Related]
5. Discovery of high in vitro and in vivo antitumor activities of organometallic ruthenium(ii)-arene complexes with 5,7-dihalogenated-2-methyl-8-quinolinol.
Meng T; Qin QP; Chen ZL; Zou HH; Wang K; Liang FP
Dalton Trans; 2019 Apr; 48(16):5352-5360. PubMed ID: 30942794
[TBL] [Abstract][Full Text] [Related]
6. ROS-independent Nrf2 activation in prostate cancer.
Bellezza I; Scarpelli P; Pizzo SV; Grottelli S; Costanzi E; Minelli A
Oncotarget; 2017 Sep; 8(40):67506-67518. PubMed ID: 28978049
[TBL] [Abstract][Full Text] [Related]
7. Potent and selective anticancer activity of half-sandwich ruthenium and osmium complexes with modified curcuminoid ligands.
Pagliaricci N; Pettinari R; Marchetti F; Pettinari C; Cappellacci L; Tombesi A; Cuccioloni M; Hadiji M; Dyson PJ
Dalton Trans; 2022 Sep; 51(35):13311-13321. PubMed ID: 35983757
[TBL] [Abstract][Full Text] [Related]
8. Dimetallic Ru(II) arene complexes appended on bis-salicylaldimine induce cancer cell death and suppress invasion via p53-dependent signaling.
Rahman FU; Bhatti MZ; Ali A; Duong HQ; Zhang Y; Ji X; Lin Y; Wang H; Li ZT; Zhang DW
Eur J Med Chem; 2018 Sep; 157():1480-1490. PubMed ID: 30282320
[TBL] [Abstract][Full Text] [Related]
9. Bipyrimidine ruthenium(II) arene complexes: structure, reactivity and cytotoxicity.
Betanzos-Lara S; Novakova O; Deeth RJ; Pizarro AM; Clarkson GJ; Liskova B; Brabec V; Sadler PJ; Habtemariam A
J Biol Inorg Chem; 2012 Oct; 17(7):1033-51. PubMed ID: 22791215
[TBL] [Abstract][Full Text] [Related]
10. Highly selective binding of organometallic ruthenium ethylenediamine complexes to nucleic acids: novel recognition mechanisms.
Chen H; Parkinson JA; Morris RE; Sadler PJ
J Am Chem Soc; 2003 Jan; 125(1):173-86. PubMed ID: 12515520
[TBL] [Abstract][Full Text] [Related]
11.
Gopalakrishnan D; Saravanan S; Merckx R; Madan Kumar A; Khamrang T; Velusamy M; Vasanth K; Sunitha S; Hoogenboom R; Maji S; Ganeshpandian M
Dalton Trans; 2021 Jun; 50(23):8232-8242. PubMed ID: 34037018
[TBL] [Abstract][Full Text] [Related]
12. A ruthenium(II)-curcumin compound modulates NRF2 expression balancing the cancer cell death/survival outcome according to p53 status.
Garufi A; Baldari S; Pettinari R; Gilardini Montani MS; D'Orazi V; Pistritto G; Crispini A; Giorno E; Toietta G; Marchetti F; Cirone M; D'Orazi G
J Exp Clin Cancer Res; 2020 Jun; 39(1):122. PubMed ID: 32605658
[TBL] [Abstract][Full Text] [Related]
13. Ruthenium(ii) p-cymene complexes of a benzimidazole-based ligand capable of VEGFR2 inhibition: hydrolysis, reactivity and cytotoxicity studies.
Bhattacharyya S; Purkait K; Mukherjee A
Dalton Trans; 2017 Jul; 46(26):8539-8554. PubMed ID: 28638907
[TBL] [Abstract][Full Text] [Related]
14. Antitumor Activity of Ruthenium(II) Terpyridine Complexes towards Colon Cancer Cells In Vitro and In Vivo.
Savic M; Arsenijevic A; Milovanovic J; Stojanovic B; Stankovic V; Rilak Simovic A; Lazic D; Arsenijevic N; Milovanovic M
Molecules; 2020 Oct; 25(20):. PubMed ID: 33066568
[TBL] [Abstract][Full Text] [Related]
15. Anticancer activity and mechanism of bis-pyrimidine based dimetallic Ru(II)(η
Bhatti MZ; Ali A; Duong HQ; Chen J; Rahman FU
J Inorg Biochem; 2019 May; 194():52-64. PubMed ID: 30831390
[TBL] [Abstract][Full Text] [Related]
16. Activation by Oxidation: Ferrocene-Functionalized Ru(II)-Arene Complexes with Anticancer, Antibacterial, and Antioxidant Properties.
Mu C; Prosser KE; Harrypersad S; MacNeil GA; Panchmatia R; Thompson JR; Sinha S; Warren JJ; Walsby CJ
Inorg Chem; 2018 Dec; 57(24):15247-15261. PubMed ID: 30495936
[TBL] [Abstract][Full Text] [Related]
17. Half-sandwich Ru(η
Huang YC; Haribabu J; Chien CM; Sabapathi G; Chou CK; Karvembu R; Venuvanalingam P; Ching WM; Tsai ML; Hsu SCN
J Inorg Biochem; 2019 May; 194():74-84. PubMed ID: 30831392
[TBL] [Abstract][Full Text] [Related]
18. ERK5 Inhibition Induces Autophagy-Mediated Cancer Cell Death by Activating ER Stress.
Gámez-García A; Bolinaga-Ayala I; Yoldi G; Espinosa-Gil S; Diéguez-Martínez N; Megías-Roda E; Muñoz-Guardiola P; Lizcano JM
Front Cell Dev Biol; 2021; 9():742049. PubMed ID: 34805151
[TBL] [Abstract][Full Text] [Related]
19. Competition between glutathione and guanine for a ruthenium(II) arene anticancer complex: detection of a sulfenato intermediate.
Wang F; Xu J; Habtemariam A; Bella J; Sadler PJ
J Am Chem Soc; 2005 Dec; 127(50):17734-43. PubMed ID: 16351102
[TBL] [Abstract][Full Text] [Related]
20. Zika Virus Induces an Atypical Tripartite Unfolded Protein Response with Sustained Sensor and Transient Effector Activation and a Blunted BiP Response.
Mufrrih M; Chen B; Chan SW
mSphere; 2021 Jun; 6(3):e0036121. PubMed ID: 34106769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
